{
    "clinical_study": {
        "@rank": "148044", 
        "arm_group": [
            {
                "arm_group_label": "Non-MGD Participants", 
                "description": "Participants without MGD who have meibum expressed as per protocol. No investigational drug is administered in this study."
            }, 
            {
                "arm_group_label": "Mild-Moderate MGD Participants", 
                "description": "Participants with Mild-Moderate MGD who have meibum expressed as per protocol. No investigational drug is administered in this study."
            }, 
            {
                "arm_group_label": "Severe MGD Participants", 
                "description": "Participants with Severe MGD who have meibum expressed as per protocol. No investigational drug is administered in this study."
            }
        ], 
        "biospec_descr": {
            "textblock": "Tears"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is an exploratory study to evaluate endpoints used to characterize participants with\n      and without meibomian gland dysfunction (MGD) and will evaluate the correlation between\n      signs and symptoms of MGD. No investigational drug will be administered in this study."
        }, 
        "brief_title": "Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Meibomian Glands", 
        "condition_browse": {
            "mesh_term": "Signs and Symptoms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -Participants characterized as with or without Meibomian Gland Dysfunction.\n\n        Exclusion Criteria:\n\n          -  Lid heating therapy, therapeutic gland expression, or meibomian gland probing within\n             12 months of enrollment\n\n          -  Contact lens use in the 30 days prior to enrollment\n\n          -  Lid hygiene within 48 hours prior to enrollment\n\n          -  Use of eye makeup within 8 hours of enrollment\n\n          -  Eyelash growth-stimulating products within 30 days prior to enrollment\n\n          -  Use of systemic vitamins and/or systemic supplements containing omega 3 fatty acids\n             within 60 days of enrollment\n\n          -  Use of systemic anti-histamines within 30 days prior to enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Participants characterized as with or without Meibomian Gland Dysfunction."
            }
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979887", 
            "org_study_id": "195263-007"
        }, 
        "intervention": {
            "arm_group_label": [
                "Non-MGD Participants", 
                "Mild-Moderate MGD Participants", 
                "Severe MGD Participants"
            ], 
            "description": "Meibum expression as per protocol. No investigational drug is administered in this study.", 
            "intervention_name": "Meibum Expression", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "link": {
            "description": "More Information", 
            "url": "http://www.allerganclinicaltrials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "3", 
        "overall_contact": {
            "email": "clinicaltrials@allergan.com", 
            "last_name": "Allergan Inc."
        }, 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Meibum Quality Score in the Study Eye as Assessed by the Investigator Using a 4-Point Scale", 
            "safety_issue": "No", 
            "time_frame": "Day 22"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979887"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}